Managed by the U.S. Medical and Scientific Affairs (MSA) Tissue Diagnostics team.
Content available on this channel is for health care professional education only and not for promotional purposes.
For additional questions, please reach out to your local/regional medical and scientific affairs contact or email us at indianapolis.msa@roche.com.
Content available on this channel is for health care professional education only and not for promotional purposes.
For additional questions, please reach out to your local/regional medical and scientific affairs contact or email us at indianapolis.msa@roche.com.
-
0 likes 174 playsDr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a guided digital review of non-small cell lung carcinoma (NSCLC) specimens stained with the Ventana…
-
0 likes 230 playsDr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides instruction on evaluating the Ventana PD-L1 (SP263) assay in non-small cell lung carcinoma (NSCLC)…
-
0 likes 372 playsDr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a brief overview of the Ventana PD-L1 (SP263) assay & staining in non-small cell lung carcinoma…
-
2 likes 43 playsReview of FDA classification of IVD assays, overview of clinical trial process as well as IVD development including analytical validation. TE-US-01092
-
0 likes 24 playsReview of preanalytic variables in immunohistochemical assay staining. TE-US-01089
-
0 likes 12 playsValidation approach for low prevalence biomarkers and biomarkers in rare diseases for IHC assays. TE-US-01072
-
0 likes 14 playsShort video on implementing IHC assays in the anatomic pathology laboratory. TE-US-01071
-
1 likes 31 playsAn overview of validation and verification of IHC in vitro diagnostic assays. TE-US-00990
-
0 likes 7 playsDr. Bharathi Vennapusa reviews CAP/ASCO 2020 guideline update for ER/PgR testing in breast cancer and how these guidelines pertain to Roche ER/PgR assays.
-
0 likes 39 playsDr. Beatrice Wegrzyniak of Roche medical and scientific affairs provides an overview of interpretation of the CINtec PLUS Cytology Assay for cervical cancer triage. …
-
1 likes 39 playsDr. Beatrice Wegrzyniak of Roche medical and scientific affairs team discusses the biomarkers that indicate cell cycle deregulation in cervical cancer screening. Part…
-
1 likes 46 playsDr. Linda Ahn from Roche Medical and Scientific Affairs team provides an introduction to the IMPACT trial data for use of biomarkers in cervical cancer triage. Part 2…
-
1 likes 15 playsDrs. Bharathi Vennapusa, Denise Croix and Katie Robertson discuss overview of NTRK fusions, testing methods, algorithms with a focus on pan-TRK IHC assay using VENTANA…
-
0 likes 17 playsIn this short video, Roche Pathologist, Michael Lynch, M.D. reviews the scoring method for the VENTANA HER2 Dual ISH assay as well as discusses scoring challenges and…
-
0 likes 19 playsRecording for Dr. Lawrence Weiss's talk on CAP Today Webinar from December 1, 2020. Title: Tracking TRK with IHC: Today’s Diagnostic Algorithms for NTRK…